The Widespread Use of Proton Pump Inhibitor (PPI) Medication Does Not Compromise the Accuracy of Serological Biomarker Test (GastroPanel ® Quick Test) in Point-of-care Diagnosis of Atrophic Gastritis Among Gastroscopy Referral Patients in India
Anticancer Research · 2026-08 · 46 (8) · 4509-4522
DOI: 10.21873/anticanres.18307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Mohinish Chabbra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fortis Hospital and Research Centre, Mohali Chandigarh, India. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Gastritis, Atrophic, Biomarkers, Point-of-Care Systems.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fortis Hospital and Research Centre, Mohali Chandigarh, India.
- GastroLab India Pvt Ltd, Maharashtra, India.
- Department of Clinical Research, Biohit Oyj, Helsinki, Finland.
- SMW Consultants, Ltd., Kaarina, Finland kasyrja@saunalahti.fi.
Zitieren
APA
Chabbra, M., Kolatkar, A., Chawla, S., Suovaniemi, O., & Syrjänen, K. (2026). The Widespread Use of Proton Pump Inhibitor (PPI) Medication Does Not Compromise the Accuracy of Serological Biomarker Test (GastroPanel ® Quick Test) in Point-of-care Diagnosis of Atrophic Gastritis Among Gastroscopy Referral Patients in India. Anticancer Research, 46(8), 4509-4522. https://doi.org/10.21873/anticanres.18307
Vancouver
Chabbra M, Kolatkar A, Chawla S, Suovaniemi O, Syrjänen K. The Widespread Use of Proton Pump Inhibitor (PPI) Medication Does Not Compromise the Accuracy of Serological Biomarker Test (GastroPanel ® Quick Test) in Point-of-care Diagnosis of Atrophic Gastritis Among Gastroscopy Referral Patients in India. Anticancer Research. 2026;46(8):4509-4522. doi:10.21873/anticanres.18307
BibTeX
@article{Chabbra2026,
author = {Chabbra, Mohinish and Kolatkar, Ajit and Chawla, Suresh and Suovaniemi, Osmo and Syrjänen, Kari},
title = {The Widespread Use of Proton Pump Inhibitor (PPI) Medication Does Not Compromise the Accuracy of Serological Biomarker Test (GastroPanel ® Quick Test) in Point-of-care Diagnosis of Atrophic Gastritis Among Gastroscopy Referral Patients in India},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4509--4522},
doi = {10.21873/anticanres.18307}
}
EUVIMED